Sotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024. In the quarter to June 2026, revenue grew 9.18%, EPS grew 533.3%, free cash flow grew 60.6% and total debt fell 3.54%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
Follow SHC
Sotera Health Company (SHC) P/E ratio
As of 16 October 2026, Sotera Health Company (SHC) trades at a P/E ratio of 31.4×. Over the past ten years it has ranged from 0.0× (December 2023) to 5,185× (December 2020); the current reading is higher than 31% of that period. That is below the Diagnostics & Research industry median of 35.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 65.3× | (28.36%) |
| FY2024 | 91.2× | (1.99%) |
| FY2023 | 93.1× | — |
| FY2022 | 0.0× | — |
| FY2021 | 56.1× | — |
| FY2020 | 0.0× | — |
| FY2019 | 4,648× | 0.00% |
| FY2018 | 4,648× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 31.1× | (10.97%) |
| Mar 2026 | 35.0× | (46.47%) |
| Dec 2025 | 65.3× | (21.09%) |
| Sep 2025 | 82.8× | (40.44%) |
| 23 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TWST Twist Bioscience Corporation compare | n/m |
| RDNT RadNet, Inc. compare | n/m |
| GRAL GRAIL, Inc. compare | n/m |
| ADPT Adaptive Biotechnologies Corporation compare | n/m |
| QGEN QIAGEN N.V. compare | 23.6× |
| CDNA CareDx, Inc. compare | 29.7× |
| VCYT Veracyte, Inc. compare | 29.9× |
| SHC Sotera Health Company | 31.4× |
| BLLN BillionToOne, Inc. compare | 95.0× |
| Diagnostics & Research industry median | 35.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)